Filing Details
- Accession Number:
- 0001209191-20-032291
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-27 16:14:20
- Reporting Period:
- 2020-05-26
- Accepted Time:
- 2020-05-27 16:14:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1419600 | Flexion Therapeutics Inc | FLXN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1487937 | Mark Stejbach | C/O Flexion Therapeutics, Inc. 10 Mall Road, Suite 301 Burlington MA 01803 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-05-26 | 2,051 | $9.75 | 2,051 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,580 | Indirect | By The Mark P. Stejbach Revocable Trust UA 07-08-2016 |
Footnotes
- The shares were purchased in connection with the Issuer's public offering.
Billionaire Hedge Funds
